These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1195 related items for PubMed ID: 18081661

  • 21. [Therapy of complications of hepatic cirrhosis].
    Töx U, Goeser T.
    Praxis (Bern 1994); 2005 May 04; 94(18):727-33. PubMed ID: 15938384
    [Abstract] [Full Text] [Related]

  • 22. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis.
    Khandwalla HE, Fasakin Y, El-Serag HB.
    Am J Gastroenterol; 2009 Jun 04; 104(6):1401-5. PubMed ID: 19491852
    [Abstract] [Full Text] [Related]

  • 23. Minimizing ascites. Complication of cirrhosis signals clinical deterioration.
    Garcia N, Sanyal AJ.
    Postgrad Med; 2001 Feb 04; 109(2):91-6, 101-3. PubMed ID: 11272697
    [Abstract] [Full Text] [Related]

  • 24. Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis.
    van Erpecum KJ.
    Scand J Gastroenterol Suppl; 2006 Feb 04; (243):79-84. PubMed ID: 16782626
    [Abstract] [Full Text] [Related]

  • 25. [Guidelines on the management of ascites in cirrhosis (2023 version)].
    Chinese Society of Hepatology, Chinese Medical Association.
    Zhonghua Gan Zang Bing Za Zhi; 2023 Aug 20; 31(8):813-826. PubMed ID: 37723063
    [Abstract] [Full Text] [Related]

  • 26. Preservation of nutritional-status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis.
    Sorrentino P, Castaldo G, Tarantino L, Bracigliano A, Perrella A, Perrella O, Fiorentino F, Vecchione R, D' Angelo S.
    J Gastroenterol Hepatol; 2012 Apr 20; 27(4):813-22. PubMed ID: 22142548
    [Abstract] [Full Text] [Related]

  • 27. [Natural course and physiopathology of ascites in the cirrhotic patient].
    Bernardi M, Colantoni A, Caraceni P, Sica G, Trevisani F.
    Ann Ital Med Int; 1996 Oct 20; 11 Suppl 2():30S-38S. PubMed ID: 9004818
    [Abstract] [Full Text] [Related]

  • 28. The management of hepatorenal syndrome.
    Carl DE, Sanyal A.
    Minerva Gastroenterol Dietol; 2009 Jun 20; 55(2):207-26. PubMed ID: 19305378
    [Abstract] [Full Text] [Related]

  • 29. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
    Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, Jimenez W, Planas R, Arroyo V.
    Hepatology; 2003 Jul 20; 38(1):258-66. PubMed ID: 12830009
    [Abstract] [Full Text] [Related]

  • 30. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis.
    Angeli P, Merkel C.
    J Hepatol; 2008 Jul 20; 48 Suppl 1():S93-103. PubMed ID: 18304678
    [Abstract] [Full Text] [Related]

  • 31. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F, Pantea L, Sniderman K.
    Hepatology; 2004 Jul 20; 40(1):55-64. PubMed ID: 15239086
    [Abstract] [Full Text] [Related]

  • 32. [The pathophysiology of ascites formation in cirrhosis of the liver].
    Benjaminov FS.
    Harefuah; 2002 Aug 20; 141(8):721-5, 760. PubMed ID: 12222138
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Physiopathology of refractory ascites and the hepatorenal syndrome].
    Arroyo V.
    Nefrologia; 2002 Aug 20; 22 Suppl 5():41-6. PubMed ID: 12107916
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. β-blockers and refractory ascites in cirrhosis: the message of a team of true scientists.
    Angeli P.
    J Hepatol; 2011 Oct 20; 55(4):743-4. PubMed ID: 21396970
    [No Abstract] [Full Text] [Related]

  • 38. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
    Choi CH, Ahn SH, Kim DY, Lee SK, Park JY, Chon CY, Moon YM, Han KH.
    J Gastroenterol Hepatol; 2005 Aug 20; 20(8):1215-22. PubMed ID: 16048569
    [Abstract] [Full Text] [Related]

  • 39. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
    Karwa R, Woodis CB.
    Ann Pharmacother; 2009 Apr 20; 43(4):692-9. PubMed ID: 19299324
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.